Hennion & Walsh Asset Management, Inc. Hutchmed (China) LTD Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 61,887 shares of HCM stock, worth $1.17 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
61,887
Previous 57,010
8.55%
Holding current value
$1.17 Million
Previous $957,000
10.66%
% of portfolio
0.06%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding HCM
# of Institutions
71Shares Held
14MCall Options Held
2.7KPut Options Held
3.7K-
General Atlantic LLC New York, NY4MShares$75.8 Million1.57% of portfolio
-
Schroder Investment Management Group London, X03.85MShares$72.9 Million0.08% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.57MShares$29.6 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$21.9 Million0.3% of portfolio
-
Acadian Asset Management LLC Boston, MA487KShares$9.22 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $3.28B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...